EUR/USD – Can It Recapture 1.2000?
After 48 hours of correction, the euro ended the day on the highs once again as it recaptured the 1.1900 level. Not even jawboning by the ECB could keep the single currency down for long. Yet the strength today wasn’t really a function of euro buyers, but dollar sellers as the market went once […]
4 Solar Stocks With Strong Growth Potential
The U.S. renewable energy industry has been experiencing solid growth over the last several years. In fact, reports suggest that U.S. renewable energy capacity has grown threefold since 2008, reaching a record 141 gigawatts at the end of 2016, according to the Business Council for Sustainable Energy. Zeroing in on the solar energy space under […]
Abolish The Fed?
We’ve been led to believe that central banks – and especially the Federal Reserve System – was put in place to protect us. That’s a laugh! Central banks are partnerships created between bankers and politicians. The political side gets spendable money (created from nothing) without having to raise taxes, while bankers get commissions or interest […]
Two Measures Of Inflation And Fed Policy – Thursday, August 31
Note: The charts below have been updated with the latest Personal Consumption Expenditures price index from the Bureau of Economic Analysis. The annualized rate of change is calculated to two decimal places for more precision in the side-by-side comparison with the Consumer Price Index. The BEA’s Personal Consumption Expenditures Chain-type Price Index for July, released today, shows that […]
Is Altria Stock A Buy After The Recent Pull Back?
For decades, Philip Morris was a dividend investors dream. A stable company that would increase its dividend annually. Then tobacco lawsuits began to pop up and the company decided to split itself up for the long term health of the company. So in 2003, Altria (NYSE: MO) was born. Since the spin off, Altria stock has […]
Breadth, Bonds, Bills, & Bear Funds Signal Trouble Ahead For Stocks
The ‘resilience’ of stock markets is proclaimed as self-reflectingly positive, as they surge higher, enthusiastically embracing debt ceiling anxiety, nuclear armageddon, and biblical floods. However, below the surface all is very much not rosy… As Bloomberg reports, this is a warning for stock traders entranced by a market that remains resilient to surprises. Even though the S&P 500 is […]
Optical Names Follow Ciena Lower As North American Equipment Spending Slows
Shares of companies in the optical component sector, including Finisar (FNSR) and Oclaro (OCLR), are following Ciena (CIEN) lower on Thursday. Ciena offered up a gloomy view of the fourth quarter earlier today, despite reporting better than expected fiscal third-quarter earnings and revenue. The declines are especially notable as the broader tech sector is rallying […]
Nemaska Lithium Inc.: A Good Candidate For Investing In The Lithium Space
TM editors note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence. Written by SmallCapPower.com Nemaska Lithium Inc. (NMKEF) has proprietary technology to produce low-cost, high-grade lithium carbonates and hydroxides which gives it a leading advantage over its peers and, given the surging demand for […]
Soros’ Worst Trade
There is this Canadian rock star who retired a few years back and took up hosting an afternoon drive-home radio show on a local Toronto station. Sometimes his program includes a segment called, “Damn! I wish I wrote that.” This ex-rock star will play a famous song on his guitar, tell the story of how it came […]
Teva’s Drug Austedo FDA Nod For Label Expansion In Dyskinesia
Teva Pharmaceutical Industries Ltd. (TEVA – Free Report) announced that the FDA has approved a label expansion for its drug, Austedo. With the latest FDA approval, Austedo’s label has been expanded to include treatment of tardive dyskinesia, a debilitating and often irreversible movement disorder. We remind investors that Austedo was approved for treating chorea associated with Huntington’s disease […]
